levoketoconazole sold brand name recorlev steroidogenesis inhibitor used treatment cushings levoketoconazole approved medical use united states december levoketoconazole levorotatory enantiomer inhibitor enzymes inhibits glucocorticoid biosynthesis hence circulating levels glucocorticoids thereby treating cushings addition increased potency drug less potent racemic ketoconazole inhibiting cholesterol theoretically resulting reduced interference bile acid production metabolite elimination therefore less risk levoketoconazole also found inhibit cholesterol sidechain cleavage enzyme similarly potently relative httpsenwikipediaorgwikilevoketoconazole